Form 8-K - Current report:
SEC Accession No. 0001104659-24-086275
Filing Date
2024-08-06
Accepted
2024-08-06 16:13:44
Documents
17
Period of Report
2024-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2418396d3_8k.htm   iXBRL 8-K 32200
2 EXHIBIT 99.1 tm2418396d3_ex99-1.htm EX-99.1 17708
3 EXHIBIT 99.2 tm2418396d3_ex99-2.htm EX-99.2 7654
7 GRAPHIC tm2418396d3_ex99-1img01.jpg GRAPHIC 3902
8 GRAPHIC tm2418396d3_ex99-2img001.jpg GRAPHIC 5088
  Complete submission text file 0001104659-24-086275.txt   253023

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pgen-20240806.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pgen-20240806_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pgen-20240806_pre.xml EX-101.PRE 22359
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2418396d3_8k_htm.xml XML 3551
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 241179412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)